Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Proteostasis

Astellas forges $675m muscle alliance with Cytokinetics

Extendscollaboration to include neuromuscular diseases

- PMLiVE

Deaths cause Amgen to drop stomach cancer drug

Increase in patient mortality in patients taking rilotumumab during trial

- PMLiVE

Astellas opens new office in Dubai

Will support operations in the Middle East, North and Sub-Saharan Africa

- PMLiVE

Astellas EMEA CEO volunteers at school

Ken Jones promotes healthy lifestyle as part of Changing Tomorrow campaign

- PMLiVE

Astellas earmarks up to $1.2bn for protein folding research

Teams up with US company to investigate diseases caused by protein defects

Astellas names president of US technologies business

Promotion for Brian McLellan

- PMLiVE

Pre-chemotherapy indication for Xtandi in prostate cancer

Astellas drug set to compete with J&J’s Zytiga

- PMLiVE

Germany’s IQWiG denies Astellas’ incontinence drug

But Janssen receives recommendation for hepatitis C treatment Olysio

- PMLiVE

Astellas makes senior EMEA appointments

Names Simon Dew and Jun Kono to new roles

- PMLiVE

Astellas appoints Moyra Knight to comms role

Will head up corporate and employee communications in the Americas

- PMLiVE

NICE backs cancer drugs from Astellas and BMS

Recommendations for Xtandi in prostate cancer and earlier use of Yervoy

- PMLiVE

Astellas appoints compliance officer for Americas region

Promotion for Tatjana Dragovic

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links